The important point is that if we consider mutations of ever-increasing magnitude, there will come a point when, the larger the mutation is, the less likely it is to be beneficial; while if we consider mutations of ever-decreasing magnitude, there will come a point when the chance of a mutation’s being beneficial is 50 per cent.
